On 14 May 2015, Robert Dow (plaintiff), a foreign investor, entered into a written Facility Agreement with what he believed to be Pomelo Mining (Pvt) Ltd (first defendant), advancing an unsecured loan of US$200,000 for gold trading purposes. The agreement stipulated repayment within 12 months (by 14 May 2016) with 1% monthly interest on overdue amounts, and was governed by English law with non-exclusive jurisdiction to English and Welsh courts. The defendant failed to repay by the due date. On 6 September 2018, the plaintiff issued summons against Pomelo Mining (Pvt) Ltd to recover the debt. The first defendant entered appearance and filed a plea on the merits in January 2019, without raising prescription or misjoinder. During proceedings, it emerged that the Facility Agreement named "Pomelo Trading (Pvt) Ltd" as the borrower, not Pomelo Mining. In 2017, representatives of the defendant allegedly acknowledged the debt at a meeting on 30 May 2017. The first defendant only raised a special plea of prescription in October 2022, years after the original plea. The plaintiff subsequently obtained leave to join Pomelo Trading (Pvt) Ltd as second defendant in 2023. Both defendants then filed special pleas of prescription and the first defendant raised an exception claiming misjoinder and no cause of action.
1. Both defendants' exception and special pleas are dismissed. 2. The defendants shall bear the costs of these preliminary proceedings, jointly and severally, the one paying the other to be absolved.
1. A special plea of prescription must be raised before or together with the plea to the merits pursuant to Rule 42 of the High Court Rules 2021, and a defendant who raises it belatedly must satisfy the Western Assurance test by proving on oath that the ground arose after pleadings or that the defendant was unaware of it despite diligence. 2. Prescription is a defense that must be raised by special plea, not by exception, as it involves introducing extraneous facts requiring evidence (following Van Brooker v Mudhanda SC 5/18 and Muzofa J in HH 658-19). 3. Service of summons interrupts the running of prescription under the Prescription Act [Chapter 8:11]. 4. Where a debtor deliberately conceals facts relevant to identifying the proper defendant, prescription does not run against the creditor until discovery of the concealment, applying principles recognized in both English law (s.32 Limitation Act 1980) and Zimbabwean law. 5. An amendment joining an additional defendant in respect of the same cause of action relates back to the date of the original summons for prescription purposes, particularly where the added party is closely related to the original defendant and had knowledge of the claim. 6. Prescription/limitation is governed by the lex fori (law of the forum) even where the contract specifies a foreign governing law for substantive rights. 7. An exception for failure to disclose a cause of action cannot succeed where the declaration alleges the essential elements of the claim (loan advanced, breach, non-repayment) and the defendant's challenge is to the factual accuracy of those allegations, which is a matter for evidence at trial.
The court made several obiter observations: (1) that it would be fundamentally unjust to allow a debtor to evade liability by exploiting corporate technicalities and running down the prescription clock; (2) that equity will not suffer a wrong without a remedy; (3) that the close relationship between Pomelo Mining and Pomelo Trading, including shared address and management, suggested they might be alter egos or that one benefited from the other's dealings; (4) that doctrines such as piercing the corporate veil or unjust enrichment might potentially apply depending on trial evidence; (5) that punitive costs on an attorney-client scale are reserved for clearly frivolous or vexatious defenses, and while the defendants' approach lacked merit, it did not rise to that level of abuse; and (6) that courts prefer to have all potentially liable parties before them to decide matters on evidence rather than on hyper-technical pleading points, as courts are courts of substantial justice. The judge also noted approvingly the principle from Clan Transport Co. (Pvt) Ltd v Pamhenyayi that misnomer of a defendant does not render proceedings a nullity if the intended target can be identified and the defendant understood it was being sued.
This case is significant in Zimbabwean civil procedure for clarifying several important principles: (1) the proper procedure for raising prescription defenses (by special plea, not exception, following Van Brooker v Mudhanda SC 5/18); (2) the stringent requirements under the Western Assurance test for raising special pleas after pleadings have closed; (3) the application of fraudulent concealment principles to prevent debtors from exploiting prescription where they have deliberately obscured the identity of the liable party; (4) the relation-back doctrine for amendments joining additional parties to existing causes of action; (5) the interaction between choice of law clauses and prescription, confirming that prescription/limitation is generally governed by lex fori (forum law) while substantive contractual rights are governed by the chosen law; and (6) the court's discretion to prevent abuse of process through tactical delayed raising of technical defenses. The judgment demonstrates the Zimbabwean courts' commitment to substantive justice over procedural technicalities and their willingness to prevent manipulation of corporate structures and prescription rules to defeat legitimate claims.